MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program - Hu, S; Xu-Monette, Z Y; Tzankov, A (Blood, 2013)
, quiz 4250